Psychotherapy with psilocybin tested against depression

December 12, 2021

Psychotherapy with psilocybin tested against depression

A clinical trial is underway to test whether psilocybin-assisted psychotherapy can help front-line clinicians who have developed depression and anxiety amid the COVID-19 pandemic. Psilocybin is a psychedelic naturally found in some mushrooms.

"Nurses right now and doctors are leaving the field in droves. We're on our way to a public health crisis because providers are leaving," said Anthony Back, the trial's lead investigator and a professor of medicine at the University of Washington School of Medicine. "This kind of mental health treatment is really a new way of thinking."

Learn more about the trial in our news release.

Access downloadable video assets with Back discussing the issues that front-line clinicians face.

Getty Images

Terms of appropriate usage of file downloads

  • News reporters and news organizations may freely republish and distribute videos, still images and audio files produced by UW Medicine and the University of Washington School of Medicine.
  • Works must be attributed/credited appropriately (for example, “UW Medicine” – as denoted in the file) and must not be used for commercial purposes.
  • These visual and audio files may not be used to exploit or misrepresent UW Medicine or the University of Washington.
  • UW Medicine often licenses still images from Thinkstock but cannot grant republishing rights. You may not republish single image files credited to Thinkstock.
  • Logos of UW Medicine and University of Washington Health Sciences schools may not be republished without explicit permission. Contact us by phone or email: 206.543.3620 or